Gore Cardioform Septal Occluder
Payments companies reported to CMS as associated with Gore Cardioform Septal Occluder. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Gore Cardioform Septal Occluder, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Gore Cardioform Septal Occluder
These are the largest totals companies reported as associated with Gore Cardioform Septal Occluder. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Matthew Gillespie | Philadelphia, PA | Pediatric Cardiology | $64,766.33 |
| Vamsee Yaganti | Salt Lake City, UT | Interventional Cardiology | $61,304.39 |
| William Crowder | Jackson, MS | Interventional Cardiology | $60,963.90 |
| Islam Abudayyeh | Redlands, CA | Interventional Cardiology | $60,831.76 |
| Joseph Paolillo | Charlotte, NC | Pediatric Cardiology | $58,763.32 |
| Bibhu Mohanty | Tampa, FL | Interventional Cardiology | $50,029.54 |
| Brent Gordon | San Diego, CA | Pediatric Cardiology | $46,398.36 |
| Gagan Singh | Sacramento, CA | Cardiovascular Disease | $46,381.42 |
| John Lasala | Saint Louis, MO | Interventional Cardiology | $45,620.08 |
| Joanna Ghobrial | Los Angeles, CA | Cardiovascular Disease | $41,562.90 |
Prescribed Gore Cardioform Septal Occluder?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.